IMUGENE CHART. TA only, page-33791

Thanks slick,

Nice chart plotting with announcement attachments.

The big up tick is the data of curing the pancreatic cancer pt, which is there go to statement with every presentation.

The following statements have been advisement of expanding the drugs, and that a step has been passed with the drugs safety efficacy, although limited pt results.

As Iv mentioned before it will rip if we have a large increase in cancer curing or a significant pause in solid tumor growth.

Until than, I guess its a great time to average down, and hopefully hold enough shares that are still of reasonable portion if a consolidation does occur.

Data is key.